Cargando…
Aβ(1–42) reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling
The reduced clearance of amyloid-β peptide (Aβ) from the brain partly accounts for the neurotoxic accumulation of Aβ in Alzheimer's disease (AD). Recently, it has been suggested that P-glycoprotein (P-gp), which is an efflux transporter expressed on the luminal membrane of the brain capillary e...
Autores principales: | Park, R, Kook, S-Y, Park, J-C, Mook-Jung, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611731/ https://www.ncbi.nlm.nih.gov/pubmed/24967961 http://dx.doi.org/10.1038/cddis.2014.258 |
Ejemplares similares
-
HMGB1 regulates P-glycoprotein expression in status epilepticus rat brains via the RAGE/NF-κB signaling pathway
por: Xie, Yuan, et al.
Publicado: (2017) -
Nanoparticulate flurbiprofen reduces amyloid-β(42) generation in an in vitro blood–brain barrier model
por: Meister, Sabrina, et al.
Publicado: (2013) -
Annexin A1 restores Aβ(1‐42)‐induced blood–brain barrier disruption through the inhibition of RhoA‐ROCK signaling pathway
por: Park, Jong‐Chan, et al.
Publicado: (2016) -
RAGE targeted strategies for Alzheimer’s amyloid β peptide induced blood brain barrier dysfunctions
por: Askarova, Sholpan, et al.
Publicado: (2013) -
PRAK mediates Aβ-RAGE driven autophagy pathway
por: Kim, Yoonhee, et al.
Publicado: (2017)